Paysign publishes transcript of Q2 2026 earnings call

Paysign raised its 2026 outlook to:

• Revenue of USD 114 million to USD 117 million
• Adjusted EBITDA of USD 35 million to USD 38 million
• 165 to 170 active programs by the end of Q3

Paysign held its Q2 2026 earnings call with CEO Mark Newcomer, CFO Jeff Baker, President of Patient Affordability Matt Turner, and Chief Payments Officer Matt Lanford.

• Revenue rose 48.1% to USD 28.3 million.
• Net income reached USD 6.8 million.
• Gross margin expanded 170 bps to 63.3%.

• Patient affordability revenue climbed 88.9% to USD 14.6 million.
• Claims increased about .